Item 9 Labs Corp. (INLB) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - Specialty & Generic Branche. Der Hauptsitz des Unternehmens ist in Phoenix, AZ, United States. Der aktuelle CEO ist Jeffrey I. Rassas.
INLB hat IPO-Datum 2012-01-25, 97 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $70.18K.
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
